Literature DB >> 29671042

Hyperbaric oxygen therapy reduces astrogliosis and helps to recovery brain damage in hydrocephalic young rats.

Stephanya Covas da Silva1, Omar Feres2, Pâmella da Silva Beggiora2, Hélio Rubens Machado2, Rafael Menezes-Reis3, João Eduardo Araújo4, Ricardo Andrade Brandão2, Luiza da Silva Lopes2.   

Abstract

PURPOSE: We investigated the possible beneficial effects that hyperbaric oxygen therapy could offer in different brain structures affected by ventriculomegaly in pup rats submitted to experimental hydrocephalus.
METHODS: Seven-day-old Wistar rats were submitted to hydrocephalus by intracisternal injection of 10% kaolin into the cisterna magna. The animals were divided into four groups: control (n = 5); control with HBOT (3ATA/2 h/day) (n = 5); untreated hydrocephalic (n = 10); hydrocephalic treated with HBOT (3ATA/2 h/day) (n = 10). The treatment with HBOT was performed daily for 14 days post-induction of hydrocephalus. To evaluate the response to treatment, behavioral tests (open field, Morris water maze, and activity monitor) were performed. After 14 days, the animals were euthanized, and the brain was removed for histological (hematoxylin-eosin and solochrome-cyanine) and immunohistochemical (GFAP and Ki-67) studies.
RESULTS: The hyperbaric treatment, although not causing changes in ventricular enlargement, resulted in a significant improvement in the behavioral performance (p = 0.0001), with greater agility and exploration of the environment, preservation of spatial memory, and greater learning capacity (p = 0.0001). Through the immunohistochemical study, the astrocytic activity (glial fibrillary acidic protein) in the corpus callosum (p = 0.0001) and in the germinative matrix (p = 0.0033) was significantly reduced as compared to that in the H group.
CONCLUSION: The results suggest that hyperbaric treatment bettered the behavioral performance and offered benefits to the structures affected by the ventricular increase helping to recover the brain damages. In this way, the HBOT it can be considered an adjuvant therapy for the treatment of hydrocephalus.

Entities:  

Keywords:  Astrocytes; Brain ischemia; Hydrocephalus; Hyperbaric oxygenation

Mesh:

Year:  2018        PMID: 29671042     DOI: 10.1007/s00381-018-3803-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  48 in total

1.  Hyperbaric Oxygen Effects on Depression-Like Behavior and Neuroinflammation in Traumatic Brain Injury Rats.

Authors:  Sher-Wei Lim; Kuan-Chin Sung; Yow-Ling Shiue; Che-Chuan Wang; Chung-Ching Chio; Jinn-Rung Kuo
Journal:  World Neurosurg       Date:  2017-01-06       Impact factor: 2.104

2.  Cerebral white matter oxidation and nitrosylation in young rodents with kaolin-induced hydrocephalus.

Authors:  Marc R Del Bigio; Osaama H Khan; Luiza da Silva Lopes; Packiasamy A R Juliet
Journal:  J Neuropathol Exp Neurol       Date:  2012-04       Impact factor: 3.685

3.  Edaravone reduces astrogliosis and apoptosis in young rats with kaolin-induced hydrocephalus.

Authors:  Camila Araújo Bernardino Garcia; Carlos Henrique Rocha Catalão; Hélio Rubens Machado; Ivair Matias Júnior; Thais Helena Romeiro; José Eduardo Peixoto-Santos; Marcelo Volpon Santos; Luiza da Silva Lopes
Journal:  Childs Nerv Syst       Date:  2016-12-17       Impact factor: 1.475

4.  Monoamine alterations during experimental hydrocephalus in neonatal rats.

Authors:  G I Chovanes; J P McAllister; A A Lamperti; A G Salotto; R C Truex
Journal:  Neurosurgery       Date:  1988-01       Impact factor: 4.654

5.  Repetitive hyperbaric oxygen therapy provides better effects on brain inflammation and oxidative damage in rats with focal cerebral ischemia.

Authors:  Li-Fan Chen; Yu-Feng Tian; Cheng-Hsien Lin; Lian-Yu Huang; Ko-Chi Niu; Mao-Tsun Lin
Journal:  J Formos Med Assoc       Date:  2014-04-29       Impact factor: 3.282

6.  Nrf2/antioxidant defense pathway is involved in the neuroprotective effects of Sirt1 against focal cerebral ischemia in rats after hyperbaric oxygen preconditioning.

Authors:  Fen Xue; Jin-Wen Huang; Pei-Yan Ding; Hong-Gang Zang; Zhi-Jian Kou; Ting Li; Juan Fan; Zheng-Wu Peng; Wen-Jun Yan
Journal:  Behav Brain Res       Date:  2016-04-27       Impact factor: 3.332

7.  The behavioral change of locomotor activity in a kaolin-induced hydrocephalus rat model: evaluation of the effect on the dopaminergic system with progressive ventricle dilatation.

Authors:  Yong Sup Hwang; Insop Shim; Jin Woo Chang
Journal:  Neurosci Lett       Date:  2009-07-16       Impact factor: 3.046

8.  Chronic hydrocephalus-induced changes in cerebral blood flow: mediation through cardiac effects.

Authors:  Stephen M Dombrowski; Soren Schenk; Anna Leichliter; Zack Leibson; Kiyotaka Fukamachi; Mark G Luciano
Journal:  J Cereb Blood Flow Metab       Date:  2006-02-22       Impact factor: 6.200

9.  Changes in cerebral blood flow during cerebrospinal fluid pressure manipulation in patients with normal pressure hydrocephalus: a methodological study.

Authors:  Brian K Owler; Alonso Pena; Shahan Momjian; Zofia Czosnyka; Marek Czosnyka; Neil G Harris; Piotr Smielewski; Tim Fryer; Tim Donvan; Adrian Carpenter; John D Pickard
Journal:  J Cereb Blood Flow Metab       Date:  2004-05       Impact factor: 6.200

10.  Differences in Cognitive Function of Rats with Traumatic Brain Injuries Following Hyperbaric Oxygen Therapy.

Authors:  Xiaonian Zhang; Xiaoyan Wang; Xinting Sun; Xiaojing Sun; Yue Zhang; Hao Zhang
Journal:  Med Sci Monit       Date:  2016-07-23
View more
  2 in total

1.  Analysis of transcriptome characteristics of UTI therapy for cerebral injury after CA/ROSC based on RNA-seq technique.

Authors:  Xiaojie Bai; Mingya Yang; Tiantian Zhu; Jun Xu; Wei Wang; Yuanyuan He; Yu Liu; Xingxing Li; Miao He; Tao Meng; Zhenzhen Wang; Hong Zhang; Lixin Zhu
Journal:  Iran J Basic Med Sci       Date:  2022-06       Impact factor: 2.532

Review 2.  Novel therapeutic modulators of astrocytes for hydrocephalus.

Authors:  Yijian Yang; Chuansen Wang; Rui Chen; Yuchang Wang; Changwu Tan; Jingping Liu; Qinghua Zhang; Gelei Xiao
Journal:  Front Mol Neurosci       Date:  2022-09-26       Impact factor: 6.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.